Holen Sie sich die Stockscreener-App
19.61
1.31%
-0.26
Handel nachbörslich:
19.61
Schlusskurs vom Vortag:
$19.87
Offen:
$19.91
24-Stunden-Volumen:
56,844
Relative Volume:
0.35
Marktkapitalisierung:
$279.87M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+4.09%
1M Leistung:
-9.71%
6M Leistung:
+19.94%
1J Leistung:
-43.16%
1-Tages-Spanne:
$19.30
$19.91
1-Wochen-Bereich:
$18.00
$19.93
52-Wochen-Spanne:
$6.875
$74.49
Neurogene Inc Stock (NGNE) Company Profile
Firmenname
Neurogene Inc
Sektor
Branche
Telefon
(877) 237-5020
Adresse
535 W 24TH STREET, NEW YORK
Vergleichen Sie NGNE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NGNE
Neurogene Inc
|
19.61 | 280.30M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Neurogene Inc Stock (NGNE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-17 | Eingeleitet | Craig Hallum | Buy |
| 2025-05-16 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-06-27 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-06-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-29 | Eingeleitet | Leerink Partners | Outperform |
| 2024-03-21 | Eingeleitet | William Blair | Outperform |
| 2024-01-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-01-05 | Eingeleitet | Stifel | Buy |
| 2024-01-04 | Eingeleitet | TD Cowen | Outperform |
Alle ansehen
Neurogene Inc Aktie (NGNE) Neueste Nachrichten
What is Neurogene Inc.’s valuation compared to sector2025 Key Lessons & Long-Term Growth Portfolio Plans - khodrobank.com
How to manage a losing position in Neurogene Inc.Weekly Stock Analysis & Weekly Top Gainers Trade List - Newser
How sentiment analysis helps forecast Neurogene Inc.Market Growth Review & Weekly Return Optimization Alerts - Newser
What’s the recovery path for long term holders of Neurogene Inc.July 2025 Sentiment & Stock Market Timing Techniques - Newser
Using data models to predict Neurogene Inc. stock movementQuarterly Profit Summary & High Accuracy Swing Trade Signals - Newser
Is Neurogene Inc. forming a bottoming baseJuly 2025 Decliners & Daily Stock Trend Reports - Newser
Is Neurogene Inc. stock reversal real or fakeTrade Entry Summary & Proven Capital Preservation Methods - Newser
What earnings revisions data tells us about Neurogene Inc.Weekly Stock Report & High Yield Stock Recommendations - Newser
Using Ichimoku Cloud for Neurogene Inc. technicalsMarket Risk Analysis & Scalable Portfolio Growth Methods - Newser
How institutional ownership impacts Neurogene Inc. stockPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser
Will Neurogene Inc. stock recover after recent dropTrade Analysis Report & Expert-Curated Trade Recommendations - Newser
Order flow analysis tools used on Neurogene Inc.2025 Market Outlook & Reliable Breakout Forecasts - Newser
Is Neurogene Inc. currently under institutional pressure2025 Winners & Losers & Fast Moving Trade Plans - khodrobank.com
Neurogene Inc. stock chart pattern explainedEarnings Growth Report & Precise Swing Trade Entry Alerts - Newser
Is Neurogene Inc. a potential multi baggerJuly 2025 Big Picture & Entry Point Strategy Guides - khodrobank.com
Chart based exit strategy for Neurogene Inc.Portfolio Value Summary & Short-Term Swing Trade Alerts - Newser
What’s the fair value of Neurogene Inc. stockSwing Trade & Community Trade Idea Sharing Platform - khodrobank.com
What technical models suggest about Neurogene Inc.’s comebackMarket Weekly Review & Weekly Momentum Picks - Newser
What momentum shifts mean for Neurogene Inc.July 2025 News Drivers & Weekly Breakout Opportunity Watchlist - Newser
Is Neurogene Inc. a play on infrastructure spendingQuarterly Investment Review & AI Based Trade Execution Alerts - khodrobank.com
What earnings revisions data tells us about Neurogene IncQuarterly Risk Review & Low Drawdown Trading Strategies - Newser
Quantitative breakdown of Neurogene Inc. recent moveLayoff News & Weekly Top Stock Performers List - Newser
Heatmap analysis for Neurogene Inc. and competitorsQuarterly Growth Report & Verified Trade Idea Suggestions - Newser
Intrinsic Value of Neurogene Inc. Stock: Is It Undervalued or Overvalued2025 Pullback Review & Long Hold Capital Preservation Tips - Newser
Will Neurogene Inc. rebound enough to break evenQuarterly Growth Report & Free Reliable Trade Execution Plans - Newser
Measuring Neurogene Inc.’s beta against major indicesWeekly Investment Report & Verified Swing Trading Watchlist - Newser
Will Neurogene Inc. Sustain Its Chart Breakout2025 Market WrapUp & Real-Time Price Movement Reports - beatles.ru
Using economic indicators to assess Neurogene Inc. potentialJuly 2025 Market Mood & Low Drawdown Momentum Ideas - Newser
Has Neurogene Inc. found a price floor2025 Market Overview & Real-Time Buy Signal Notifications - Newser
Should you hold or exit Neurogene Inc. now2025 Bull vs Bear & Safe Capital Growth Tips - Newser
Volume Profile Shows Strong Base for Neurogene Inc. getLinesFromResByArray error: size == 0 - newsyoung.net
Will Neurogene Inc. bounce back from current supportWeekly Investment Recap & Weekly Return Optimization Plans - Newser
Neurogene Inc. stock trend outlook and recovery path2025 Key Lessons & Expert Approved Momentum Trade Ideas - Newser
Finanzdaten der Neurogene Inc-Aktie (NGNE)
Es liegen keine Finanzdaten für Neurogene Inc (NGNE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):